Cabozantinib-related pneumothorax in responsive patients with renal cell carcinoma: a case report
Abstract Background Cabozantinib is a multi-kinase inhibitor that has been shown to be effective in the treatment of unresectable or metastatic renal cell carcinoma and unresectable hepatocellular carcinoma that worsened after anticancer drug therapy. Tyrosine kinase inhibitors (TKIs) are known to s...
Uloženo v:
| Hlavní autoři: | , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BMC
2026-07-01
|
| Edice: | Journal of Medical Case Reports |
| Témata: | |
| On-line přístup: | https://doi.org/10.1186/s13256-026-06030-x |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|